Report : Middle East & Africa Platelet Rich Plasma Tube Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Usage (Skin Rejuvenation, Hair Restoration, Orthopedics, Surgical Oncology, Gynecology, and Others), Volume (Less Than 5 ML, 6 ML TO 10 ML, and More Than 10 ML), and End User (MedSpas, Dermatology Offices, Hospitals and Healthcare Practices, Tricologist Practices, and Others)
At 16.6% CAGR, the Middle East & Africa Platelet Rich Plasma Tube Market is speculated to be worth US$ 99.28 million by 2028, says Business Market Insights
According to Business Market Insights’ research, the Middle East & Africa platelet rich plasma tube market was valued at US$ 39.57 million in 2022 and is expected to reach US$ 99.28 million by 2028, registering a CAGR of 16.6% from 2022 to 2028. Growing number of medical spas and increasing cases of sports injuries are the critical factors attributed to the Middle East & Africa platelet rich plasma tube market expansion.
The wellness program in Oman has incorporated traditional healing practices and pampering treatments that include a hammam and natural hot springs. Also, the growing success of medical spas in the Middle East is attributed to various features of the facility, including traditional spa comforts and cosmetic procedures. In the Middle East, the UAE is the region's largest medical spa service provider. Further, Dubai has a high concentration of medical spas per capita across the world. Therefore, the rising number of medical spas offering cosmetic procedures using PRP injections is expected to fuel the platelet-rich plasma (PRP) tube market growth in the coming years.
On the contrary, high cost and adverse effects of platelet-rich plasma treatment hurdles the growth of Middle East & Africa platelet rich plasma tube market.
Based on usage, the Middle East & Africa platelet rich plasma tube market is segmented into skin rejuvenation, hair restoration, orthopedics, surgical oncology, gynecology, and others. The others segment held 25.9% share of Middle East & Africa platelet rich plasma tube market in 2022, amassing US$ 10.29 million. It is projected to garner US$ 25.13 million by 2028 to expand at 16.0% CAGR during 2022–2028. The skin rejuvenation segment is further sub segmented into scars, skin aging, acne, skin ulcers, and others.
Based on volume, the Middle East & Africa platelet rich plasma tube market is segmented into less than 5 ml, 6ml to 10 ml, and more than 10 ml. The more than 10 ml segment held 62.6% share of Middle East & Africa platelet rich plasma tube market in 2022, amassing US$ 24.76 million. It is projected to garner US$ 61.22 million by 2028 to expand at 16.3% CAGR during 2022–2028.
Based on end user, the Middle East & Africa platelet rich plasma tube market is segmented into medspa, dermatology office, hospitals & healthcare practice, tricologist, and others. The hospitals & healthcare practice segment held 35.5% share of Middle East & Africa platelet rich plasma tube market in 2022, amassing US$ 14.03 million. It is projected to garner US$ 35.05 million by 2028 to expand at 16.5% CAGR during 2022–2028.
Based on country, the Middle East & Africa platelet rich plasma tube market has been categorized into Saudi Arabia, South Africa, UAE, Egypt, Turkey, Algeria, Qatar, Morocco, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 26.4% share of Middle East & Africa platelet rich plasma tube market in 2022. It was assessed at US$ 10.44 million in 2022 and is likely to hit US$ 27.08 million by 2028, exhibiting a CAGR of 17.2% during the forecast period.
Key players profiles in the Middle East & Africa platelet rich plasma tube market report AdvaCare Pharma USA LLC; ADVIN HEALTH CARE; BIO-X; Henso Medical (Hangzhou) Co Ltd; Lingen Precision Medical Products Co Ltd; and Manso Medical Co Ltd, among others.
Contact Us
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email id: sam@businessmarketinsights.com